Advertising disclosure — We may earn a commission if you start care through some of these links, at no extra cost to you. How we're funded. Order reflects our editorial rubric and our commercial relationships; scores are ours alone.
Head-to-head for women
He & She MD vs HealthSource
He & She MD and HealthSource both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
He & She MD
Higher scoreRanked #25 for women · Grade B−
Luna Fit
Best for: Women who want the GLP-1 and the hormone conversation handled by one clinician rather than split across two providers, and who will read the asterisk before choosing a plan length.
Visit He & She MDHealthSource
Ranked #67 for women · Grade C
Luna Fit
Best for: Women who want an oral tirzepatide option and a documented nationwide footprint, and who will read the four-week billing cycle rather than assuming it is monthly.
Visit HealthSourceThe verdict for women
He & She MD edges out HealthSource on the Luna Fit Score, 80 to 74 (B− vs C). Women who want the GLP-1 and the hormone conversation handled by one clinician rather than split across two providers, and who will read the asterisk before choosing a plan length. The reasoning behind that number is in the He & She MD scorecard.
HealthSource is still a genuine option — one of the few programs that documents its all-50-state footprint rather than asserting it, with an oral tirzepatide route and a starter-dose plan priced the same as the full dose. Weigh the six women's-health factors below against your own priorities; what we found reviewing HealthSource goes through each of them, and if neither of these two is the one, what women pick instead of HealthSource widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | He & She MD | HealthSource |
|---|---|---|
| Luna Fit Score | 80/100 · B− | 74/100 · C |
| Overall rank | #25 | #67 |
| Semaglutide | $199/mo month-to-month ($1,188 once for a year is the $99/mo on the banners) | $199 every 4 weeks (13 charges a year; $174.50 per 4 weeks on the 8-week plan) |
| Tirzepatide | $299/mo month-to-month ($1,908 committed for the year) | $299 every 4 weeks (13 charges a year; $274.50 per 4 weeks on the 8-week plan) |
| Coverage | Every US state except Louisiana for GLP-1s; hormone and longevity lines ship nationwide | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Luna Fit
He & She MD
Ranked #25 · Grade B−
What we like
- Sells estradiol (patch, gel and pill) and progesterone alongside its GLP-1s, so the menopause and metabolic sides run through one intake
- Prices four commitment terms per GLP-1 molecule in public, with the amount actually charged printed beside each
- Names the dispensing pharmacy in full — F&F Pharmacies Inc, doing business as Jungle Jim's Pharmacy, 5484 Dixie Highway, Fairfield OH 45014, with a phone number
The caveats
- The menopause line is the one place it stops publishing terms: estradiol patch, gel and pill and the progesterone pill all show "Starting at $125/month" with no term table at all, while seven other product pages carry a full four-rung ladder
- Every advertised GLP-1 figure is the twelve-month rung — the "$99/month" on the banners requires $1,188 paid once, and the rate you can stop after a month is $199
- Its FAQ says the pharmacy it names is licensed in 44 states and cannot dispense sterile compounds; a weekly GLP-1 injection is a sterile compound, and a second pharmacy is named in the same answer without saying which fills what
Luna Fit
HealthSource
Ranked #67 · Grade C
What we like
- The only provider in this batch whose all-50-state claim is documented on its own service-areas page rather than asserted in marketing copy
- An oral tirzepatide program alongside the injections
- Starter-dose and full-dose plans cost the same, so titrating up does not raise the bill
The caveats
- Billed every four weeks, not monthly — thirteen charges a year, so the effective annual cost is about 8% above the sticker
- Never actually claims flat pricing across all doses; the variants it sells happen to cost the same
- The form of the oral tirzepatide — sublingual, troche or swallowed tablet — is not disclosed anywhere
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither He & She MD nor HealthSource is only worth comparing with the other. He & She MD is also written up against CoreAge Rx, 13 points apart on the Luna Fit Score — see He & She MD against CoreAge Rx, factor by factor. HealthSource is also written up against CoreAge Rx, 19 points apart — see how HealthSource and CoreAge Rx compare on the Luna Fit Score.
- He & She MD vs CoreAge Rx
- He & She MD vs Enhance MD
- He & She MD vs Eden
- HealthSource vs yourEra
- HealthSource vs Sesame Care
- HealthSource vs HealthRX
Or browse the full comparison hub.